These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight. Sharma JC; Ross IN; Rascol O; Brooks D Eur J Neurol; 2008 May; 15(5):493-6. PubMed ID: 18355302 [TBL] [Abstract][Full Text] [Related]
25. Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease. Fox S; Silverdale M; Kellett M; Davies R; Steiger M; Fletcher N; Crossman A; Brotchie J Mov Disord; 2004 May; 19(5):554-60. PubMed ID: 15133820 [TBL] [Abstract][Full Text] [Related]
26. Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Mizuno Y; Abe T; Hasegawa K; Kuno S; Kondo T; Yamamoto M; Nakashima M; Kanazawa I; Mov Disord; 2007 Oct; 22(13):1860-5. PubMed ID: 17618525 [TBL] [Abstract][Full Text] [Related]
27. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis. Arnold G; Trenkwalder C; Schwarz J; Oertel WH Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949 [No Abstract] [Full Text] [Related]
28. Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease. Rice JE; Antic R; Thompson PD Mov Disord; 2002 May; 17(3):524-7. PubMed ID: 12112201 [TBL] [Abstract][Full Text] [Related]
29. Treatments for Parkinson's disease. Health News; 2000 Jun; 6(6):8. PubMed ID: 10865523 [No Abstract] [Full Text] [Related]
30. Levodopa in the early treatment of Parkinson's disease. Murata M Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036 [TBL] [Abstract][Full Text] [Related]
32. Direct and indirect pathways in levodopa-induced dyskinesia: a more complex matter than a network imbalance. Ghiglieri V; Picconi B; Calabresi P Mov Disord; 2010 Aug; 25(11):1527-9. PubMed ID: 20623774 [No Abstract] [Full Text] [Related]
33. Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade). Sharma JC; Macnamara L; Hasoon M; Vassallo M; Ross I Parkinsonism Relat Disord; 2006 Dec; 12(8):499-505. PubMed ID: 16935018 [TBL] [Abstract][Full Text] [Related]
34. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Bezard E; Brotchie JM; Gross CE Nat Rev Neurosci; 2001 Aug; 2(8):577-88. PubMed ID: 11484001 [TBL] [Abstract][Full Text] [Related]
35. Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease. Merims D; Ziv I; Djaldetti R; Melamed E Lancet; 1999 May; 353(9166):1764-5. PubMed ID: 10347995 [No Abstract] [Full Text] [Related]
36. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease. Zesiewicz TA; Sullivan KL; Maldonado JL; Tatum WO; Hauser RA Mov Disord; 2005 Sep; 20(9):1205-9. PubMed ID: 15954135 [TBL] [Abstract][Full Text] [Related]
37. The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia. Zhang YH; Tang BS; Song CY; Xu Q; Lou MX; Liu ZH; Yu RH; Yan XX; Guo JF Neurosci Lett; 2013 Nov; 556():109-12. PubMed ID: 24135335 [TBL] [Abstract][Full Text] [Related]
38. [A clinical analysis of L-dopa induced dyskinesia treated by posteroventral pallidotomy for Parkinson's disease]. Zhao G; Li Y; Shao M; Ding Y Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):482-4. PubMed ID: 11829894 [TBL] [Abstract][Full Text] [Related]